Our annual look back at some of the top stories about cancer research and cancer care in the past year.
The Cancer Research Institute fosters research in cancer immunology to develop more effective life-saving treatments for all types of cancer.
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
How is the practice of “step therapy” affecting patients?
In the next decade, we’re likely to know much more about our individual risks for a variety of diseases and conditions based on the information contained in our genomes.
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
Let’s keep moving forward in 2017 and address health care access issues, including out-of-pocket costs, that are priorities for most Americans.
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.